How bacteria could help create a new generation of anti-cancer medicines

For decades, scientists have known that certain bacteria can produce some of nature's most powerful anti-cancer compounds.

What they couldn't explain was how.

The microbes appeared to make several versions of the same cancer-fighting molecule with very little biological machinery. This surprising ability had puzzled researchers and made it hard to recreate or improve these compounds in the lab.

Now, a team of scientists believes it has found the answer.

Researchers from the University of Warwick and Monash University say they have found the molecular "recipe" that bacteria use to make different versions of powerful anti-cancer drugs. This discovery could help scientists create better, nature-inspired medicines and speed up the development of treatments for cancers that are still hard to treat.

The key to the discovery is tiny molecular regions called docking domains. Instead of making each drug from the beginning, bacteria use these domains as connectors. This lets different enzymes work together to build slightly different versions of the same compound.

"It's the breakthrough we needed to actually engineer these drugs ourselves," lead researcher Dr Munro Passmore of the University of Warwick said after the findings were published.

The finding solves a long-standing puzzle in natural product chemistry.

Many of today's medicines originated in bacteria, fungi and other microorganisms. Several widely used chemotherapy drugs, including doxorubicin, daunorubicin and bleomycin, trace their origins to bacteria belonging to the Streptomyces family. Scientists have long viewed these microbes as miniature chemical factories capable of producing complex molecules that are difficult to manufacture synthetically.

Until now, however, researchers did not fully understand how bacteria could generate so many different versions of these molecules without requiring an entirely separate production system for each one.

The new mechanism shows that nature uses a much more efficient method. By mixing and matching enzyme partners through shared molecular connectors, it can create many different compounds from the same process.

Researchers believe this discovery could one day help scientists redesign these natural assembly lines. This could lead to drug variants that work better against certain cancers or cause fewer side effects.

This research is still in its early stages. It is not a new cancer treatment, and clinical trials are not about to start. Instead, it gives scientists a blueprint that could help guide future drug discovery.

This breakthrough is part of a bigger trend in cancer research, where scientists are looking to nature for solutions. Researchers are searching for natural compounds from bacteria, fungi, and marine life that could become medicines. In recent years, some experimental therapies from microbes have shown promise in labs and animal studies, but most are still far from being used in patients.

For now, the biggest achievement is understanding a process that had remained hidden for decades.

By figuring out how bacteria make their own cancer-fighting molecules, researchers hope they can now start designing even better ones.